Our Pricing

Weight Loss Medication Discount Code UK: Save £10 Today

Published on: June 03, 2026

Searching for a weight loss medication discount code uk that actually delivers genuine savings? At Cured Pharmacy, new patients Save £10 on prescription weight loss treatments including Mounjaro, Wegovy, and Saxenda. Our UK-registered clinical team provides free online consultations, transparent upfront pricing, and 100% discreet delivery across the United Kingdom.

How to Claim Your £145 Weight Loss Medication Discount

Redeeming your discount code is straightforward at Cured Pharmacy. Simply complete your free online consultation—which takes under three minutes—and our UK-registered prescribers will assess your suitability for weight loss medication. If approved, apply code WEIGHTLOSSNEW at checkout to receive your discount on eligible treatments.

Unlike some online pharmacies that hide final costs until after consultation, we display transparent pricing before you begin. This means you'll know exactly what you're paying from the outset, with no unexpected fees or subscription charges. All medications are genuine UK-licensed products dispensed by our GPhC-registered pharmacy (9012511), overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Understanding GLP-1 Weight Loss Injections: Clinical Evidence

The most effective prescription weight loss medications available in the UK today are GLP-1 receptor agonists—injectable treatments that work by mimicking natural hormones that regulate appetite and blood sugar. These include semaglutide (found in Wegovy) and tirzepatide (the active ingredient in Mounjaro), both licensed by the MHRA for chronic weight management [1].

Tirzepatide represents a significant advancement as the first dual GIP/GLP-1 receptor agonist. In the SURMOUNT-1 trial, participants receiving the highest tirzepatide dose achieved an average body weight reduction of 22.5% over 72 weeks—substantially higher than previous weight loss medications [1]. Semaglutide also demonstrates robust efficacy, with the STEP trials showing average weight loss of 14.9% at 68 weeks in adults with obesity [2].

How These Medications Work in Your Body

GLP-1 receptor agonists slow gastric emptying, increase feelings of fullness after meals, and reduce appetite signals in the brain. Tirzepatide's dual mechanism also activates GIP receptors, which may enhance insulin response and further support weight reduction. Both medications are administered via once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm [1][2].

Your UK prescriber will start you on a lower dose and gradually increase it over several weeks. This dose escalation approach minimises gastrointestinal side effects whilst allowing your body to adjust to the medication. Most patients begin seeing meaningful weight loss within the first 8-12 weeks of treatment, with continued improvement over subsequent months [3].

Mounjaro vs Wegovy: Comparing the Leading Weight Loss Treatments

Both Mounjaro and Wegovy are once-weekly injectable medications licensed in the UK for chronic weight management in adults with a BMI of 30 or above, or 27 or above with weight-related health conditions. The key difference lies in their mechanisms: Mounjaro activates both GIP and GLP-1 receptors, whilst Wegovy targets GLP-1 receptors alone [1][2].

Clinical trial data suggests tirzepatide may produce greater average weight loss than semaglutide, though individual responses vary considerably. Head-to-head studies show tirzepatide users achieving approximately 5-8 percentage points more body weight reduction compared to semaglutide at equivalent treatment durations [4]. However, both medications require commitment to dietary changes and increased physical activity for optimal results.

Which Treatment Is Right for You?

Your UK prescriber will consider multiple factors when recommending a weight loss medication: your BMI, medical history, current medications, previous weight loss attempts, and personal preferences. Some patients tolerate one medication better than another, and cost may also influence your decision. At Cured Pharmacy, we stock the full range of MHRA-licensed options so your prescriber can select the most appropriate treatment for your individual circumstances.

It's worth noting that weight loss medications work best as part of a comprehensive programme including dietary modification, regular physical activity, and behavioural support. Your prescriber may recommend additional resources or follow-up consultations to optimise your treatment outcomes and ensure you're progressing safely towards your weight management goals.

Alternative Weight Loss Medications: Saxenda and Orlistat

Whilst Mounjaro and Wegovy represent the latest advances in weight management, other effective options exist for UK patients. Saxenda contains liraglutide, an earlier GLP-1 receptor agonist that requires daily injection rather than weekly administration. In clinical trials, Saxenda produced average weight loss of 8% over 56 weeks in adults with obesity [5].

Orlistat works through an entirely different mechanism—it blocks approximately 30% of dietary fat absorption in your digestive system. Available as prescription-strength Xenical or lower-dose Alli and Orlos, orlistat suits patients who prefer oral medication or have contraindications to injectable treatments. Average weight loss with orlistat ranges from 5-10% when combined with a reduced-calorie diet, though gastrointestinal side effects can occur if you consume high-fat meals [6].

What to Expect During Your Online Consultation

Our free online consultation takes under three minutes and covers essential medical information your prescriber needs to assess your suitability for weight loss medication. You'll answer questions about your current weight and height, previous weight loss attempts, existing medical conditions, current medications, and any allergies or adverse reactions you've experienced.

A UK-registered prescriber reviews every consultation individually—we never use automated approvals. If weight loss medication is appropriate for you, your prescriber will determine the most suitable treatment and starting dose based on clinical guidelines and your individual circumstances. You'll receive clear instructions on how to administer your medication, what side effects to monitor, and when to seek medical advice. All prescription medications are subject to prescriber approval and cannot be guaranteed until your consultation is reviewed.

Discreet Delivery and Ongoing Support

Once your prescription is approved, we dispense your medication from our UK pharmacy and arrange discreet delivery to your chosen address. All packaging is plain and unmarked, with no indication of contents. Most orders are dispatched within 24 hours, with delivery typically taking 1-3 working days depending on your location.

We're available by phone on (+44) 116 4646009 if you have questions about your treatment or need support between prescriptions. Many patients continue their weight loss medication for several months or longer, and we make reordering straightforward through your online account. Your prescriber will recommend appropriate follow-up intervals to monitor your progress and adjust your treatment as needed.

Safety Considerations and Common Side Effects

GLP-1 receptor agonists are generally well-tolerated, but like all medications, they can cause side effects. The most common are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These effects typically occur during dose escalation and often improve as your body adjusts to the medication [1][2][3].

More serious but rare side effects include pancreatitis, gallbladder problems, and changes in heart rate. Your prescriber will discuss warning signs to watch for and when to seek immediate medical attention. Weight loss medications are not suitable for everyone—they're contraindicated in pregnancy, during breastfeeding, and in patients with certain medical conditions including medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [7].

Always inform your prescriber of all medications you're taking, including over-the-counter products and supplements. GLP-1 medications can affect the absorption of oral medications, particularly those requiring precise timing. If you experience persistent or severe side effects, contact your prescriber or seek medical advice promptly. Never adjust your dose without consulting a healthcare professional.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. Medicines and Healthcare products Regulatory Agency. (2023). Glucagon-like peptide-1 (GLP-1) receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
8. Wadden, T. A., Hollander, P., Klein, S., et al. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451. https://doi.org/10.1038/ijo.2013.120 [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and lifestyle changes. Past clinical trial results do not guarantee individual outcomes.